Literature DB >> 20429007

Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation.

Patrícia A Macêdo1, Carolina B Garcia, Monique K Schmitz, Levi H Jales, Rosa M R Pereira, Jozélio F Carvalho.   

Abstract

To report a case of triple association of juvenile systemic lupus erythematosus (SLE), juvenile dermatomyositis and urticarial vasculitis as well as a review of the relevant literature. A 12-year-old male patient diagnosed with overlap syndrome between SLE and juvenile dermatomyositis since 2004 evolved with erythematous plaques, which were compatible with an urticarial rash. Clinical, laboratory and histopathological findings indicated a diagnosis of urticarial vasculitis. The patient previously had a C1q deficiency. Using the established treatment with methylprednisolone (1 g/day for 3 days), increasing doses of deflazacort and introduction of a dapsone, as well as mycophenolate mofetil regimen, with the suspension of azathioprine resulted in complete resolution of skin lesions. Urticarial vasculitis can present in various diseases. In SLE, presentation of urticarial vasculitis in children is rarely found. The triple association of juvenile-onset SLE, juvenile dermatomyositis and urticarial vasculitis is unusual, and this is the first case described in literature.

Entities:  

Mesh:

Year:  2010        PMID: 20429007     DOI: 10.1007/s00296-010-1484-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

1.  Inflammatory myositis complicating hypocomplementemic urticarial vasculitis despite on-going immunosuppression.

Authors:  Gary Y J Chew; Paul A Gatenby
Journal:  Clin Rheumatol       Date:  2006-08-30       Impact factor: 2.980

2.  Refractory urticarial vasculitis responsive to anti-B-cell therapy.

Authors:  C Mukhtyar; S Misbah; J Wilkinson; P Wordsworth
Journal:  Br J Dermatol       Date:  2008-12-11       Impact factor: 9.302

3.  Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome.

Authors:  F C McDuffie; W M Sams; J E Maldonado; P H Andreini; D L Conn; E A Samayoa
Journal:  Mayo Clin Proc       Date:  1973-05       Impact factor: 7.616

Review 4.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases.

Authors:  D R Mehregan; M J Hall; L E Gibson
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

5.  Subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome.

Authors:  B M S Al Riyami; J K Al Kaabi; E M Elagib; H S El Khatim; N J Y Woodhouse
Journal:  Clin Rheumatol       Date:  2003-10       Impact factor: 2.980

6.  A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients.

Authors:  C Tosoni; F Lodi-Rizzini; M Cinquini; G Pasolini; M Venturini; R A Sinico; P Calzavara-Pinton
Journal:  Clin Exp Dermatol       Date:  2008-08-02       Impact factor: 3.470

7.  Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India.

Authors:  C V P Dincy; R George; M Jacob; E Mathai; S Pulimood; E P Eapen
Journal:  J Eur Acad Dermatol Venereol       Date:  2008-03-07       Impact factor: 6.166

8.  Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child.

Authors:  Marco A Yamazaki-Nakashimada; Carola Duran-McKinster; Nadia Ramírez-Vargas; Victor Hernandez-Bautista
Journal:  Pediatr Dermatol       Date:  2009 Jul-Aug       Impact factor: 1.588

9.  Cutaneous manifestations of primary Sjögren's syndrome: a reflection of vasculitis and association with anti-Ro(SSA) antibodies.

Authors:  E L Alexander; T T Provost
Journal:  J Invest Dermatol       Date:  1983-05       Impact factor: 8.551

10.  Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis.

Authors:  Joyce Siong See Lee; Teck Hiong Loh; Swee Chong Seow; Suat Hoon Tan
Journal:  J Am Acad Dermatol       Date:  2007-06       Impact factor: 11.527

View more
  5 in total

1.  Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis.

Authors:  Lisbeth Aranbicia Aguila; Michelle Remião Ugolini Lopes; Flavia Zon Pretti; Percival Degrava Sampaio-Barros; Fernando Henrique Carlos de Souza; Eduardo Ferreira Borba; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2014-07-04       Impact factor: 2.980

2.  Mycophenolate mofetil in juvenile dermatomyositis: a case series.

Authors:  Rawane Dagher; Marine Desjonquères; Agnès Duquesne; Pierre Quartier; Brigitte Bader-Meunier; Michel Fischbach; Vincent Guiguonis; Georges Picherot; Rolando Cimaz
Journal:  Rheumatol Int       Date:  2010-12-09       Impact factor: 2.631

3.  Diffuse lymphadenopathy as the presenting manifestation of systemic lupus erythematosus.

Authors:  Lanaya Williams Smith; Allan C Gelber; Michelle Petri
Journal:  J Clin Rheumatol       Date:  2013-10       Impact factor: 3.517

Review 4.  Systemic lupus erythematosusmyositis overlap syndrome: report of 6 cases.

Authors:  Fatma Maazoun; Faten Frikha; Mouna Snoussi; Neila Kaddour; Hatem Masmoudi; Zouhir Bahloul
Journal:  Clin Pract       Date:  2011-11-02

5.  Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Authors:  Javier Loricera; Vanesa Calvo-Río; Cristina Mata; Francisco Ortiz-Sanjuán; Marcos A González-López; Lino Alvarez; M Carmen González-Vela; Susana Armesto; Héctor Fernández-Llaca; Javier Rueda-Gotor; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.